Table 3.
HRG low (N=5) |
HRG high (N=7) |
All patients (N=12) |
|
Objective response rate, N (%) | 0 | 3 (42.9) | 3 (25.0) |
Disease control rate, N (%) | 4 (80.0) | 7 (100) | 11 (91.7) |
PFS, median (95% CI), days | 100 (38, 196) | 122 (65, 217) | 122 (81, 217) |
HRG, heregulin;PFS, progression-free survival; RECIST, response evaluation criteria in solid tumours.